Krystal Biotech
Krystal Biotech, Inc. (NASDAQ:KRYS) is a pivotal-stage gene therapy company leveraging its novel, redosable gene therapy platform and in-house manufacturing capabilities to develop therapies to treat serious rare diseases.
Last updated on
About Krystal Biotech
Founded
2015Estimated Revenue
$10M-$50MEmployees
51-250Funding / Mkt. Cap
$546MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
28NAICs Code
325414Location
City
PittsburghState
PennsylvaniaCountry
United StatesTech Stack (100)
Programming Languages And Frameworks
Devops And Development
Platform And Storage
Business Intelligence And Analytics
Productivity And Operations
Finance And Accounting
Customer Management
IT Security
Sales
Computer Networks
Operations Software
Communications
Collaboration
Analytics and Tracking
Widgets
WPForms
Slack
Cloudflare Bot Manager
Divi Supreme
OneTrust
reCAPTCHA
Yoast Plugins
Wordpress Plugins
Google Font API
Sitelinks Search Box
ShareThis
GDPR Consent Management Platform
Font Awesome
MimeTypes Link Icons
CrUX Dataset
YourAdChoices.com
Popup Builder
WP Smart Preloader
Google Tag Manager
US Privacy User Signal Mechanism
Cloudflare Radar
